As we close out 2025, we reflect on a year that has been both challenging and inspiring for the clinical research industry. From regulatory uncertainties and trial delays to the promise of increased investment and the transformative power of AI, this year has reminded us why resilience and innovation matter.
At SDC, we’ve not only weathered the turbulence—we’ve thrived. Our commitment to empowering better clinical decisions has never been stronger, and as we look ahead to 2026, we pause to celebrate the milestones that defined this year.
This year marked two decades of advancing clinical research with precision and purpose. We honored this milestone in our blog: Celebrating 20 Years of Excellence. Empowering Clinical Decisions – with AI.
Read Blog - Celebrating 20 Years of Excellence. Empowering Clinical Decisions - with AI
We established four new collaborations with world-class CROs, enabling them to leverage our technology to empower clinical decisions for their sponsors.
Our statistical expertise supported two NDA submissions this year—critical steps toward bringing life-saving therapies to patients.
We appointed Faith Kolb as President and COO, reinforcing our commitment to operational excellence and strategic growth.
Read Press Release: Faith Haines Kolb Appointed President and Chief Operating Officer of SDC - SDC Clinical
Get your copy of SDC’s Practical Guide to Implementing AI in Clinical Oversight — featuring actionable frameworks for stakeholder alignment, vendor evaluation, and sustainable AI adoption.
SDC celebrates 20 years of empowering clinical decisions. Discover our journey from a biometrics CRO to a fully tech-enabled CRO—and learn how SDC...
We invited SDC's Adam Hamm, Senior VP of Statistics & Strategic Consulting to field this commonly asked question.
SDC leaders in biostatistics and clinical data management address the biggest mistakes clinical research sponsors and CRO's make with their...